Ferredoxin reductase and CYP11A1 are key proteins interacting with the FDX1 gene, and ccRCC with an FDX1 enzyme defect was associated with a low number of invading immune cells and their corresponding marker. This evidence concerns the gene CYP11A1 and nonpapillary renal cell carcinoma.